Action

MSC Income Fund Surprises Investors with Dividend Announcement

MSC Income Fund, Inc. has announced its first dividend declaration since listing on the NYSE, offering a $0.35 regular dividend and a $0.01 supplemental dividend per share to be distributed on May 1, 2025. The company focuses on providing financial support to

7 March 2025

Action·News·SOUN

Why UnitedHealth Group’s Impressive ROE Is Not Translating Into Growth

UnitedHealth Group’s stock has declined by 11% in the past three months, despite strong financial metrics. The company’s Return on Equity (ROE) is 15%, significantly higher than the industry average of 11%, indicating efficient profit generation. UnitedHealth’s net income growth averages only

7 March 2025

Action·Alphabet·Google·News·YouTube

Nasdaq’s Dramatic Decline: The Golden Opportunity for Savvy Investors

Market downturns present opportunities for value-oriented investors to acquire promising stocks at discounted prices. Alphabet stands out as a tech leader with strong search dominance and a growing cloud segment, trading at less than 17 times forward earnings. York Water Company shines

7 March 2025

*EN·Action·News

Xeris Biopharma’s Impressive Leap: Surpassing Expectations and Shaping the Future

Xeris Biopharma reported over $203 million in revenue for 2024, a 24% increase from the previous year. The product Recole experienced a 118% revenue surge due to strategic expansion and strengthening of prescriber relationships. Caveyas faced a 13% revenue decline, challenged by

7 March 2025

Action·Intel·Meta·News·Oil·YouTube

Markets Unsettled: Tumultuous Week of Trade Policies and Rising Borrowing Costs

Global markets experienced a volatile week due to U.S. trade policy shifts and rising global borrowing costs. The Nasdaq entered correction territory, primarily affected by economic uncertainties linked to U.S. trade tactics and tariffs. Currencies like the yen and Swiss franc became

7 March 2025

*AR·Action·Google·Intel·News·Paramount·YouTube

Surprise Developments at Domo: A Leap in Strategic Partnerships and Client Retention Drives Remarkable Growth

Domo is making significant strides in the data analytics platform space, focusing on consumption-based pricing and strategic partnerships to enhance growth. The shift to consumption-based billing now accounts for over 65% of Domo’s annual recurring revenue, a substantial increase from 5% two

7 March 2025

*PL·Action·Amazon·Apple·News·YouTube

Costco Unveils Bold Expansion Plans and Strong Financials: What It Means for Shoppers

Costco reported a 9.1% increase in net sales, reaching $62.53 billion, reflecting strong customer trust and business agility. 28 new warehouse openings are planned for the fiscal year, expanding Costco’s global presence with the launch of its 900th location. Gas station hours

7 March 2025

Action·News·YouTube

What the Future Holds for Small-Cap Stocks: A Deep Dive with LiveRamp Holdings

Small-cap stocks, with market caps between $300 million and $2 billion, present both challenges and opportunities in 2025. Evolving economic policies and rising interest rates create a complex environment for small-cap stocks, which depend more on borrowing. LiveRamp Holdings, Inc. (NYSE:RAMP) is

7 March 2025

*CH·Action·News

The Hidden Gems: Why Cash-Rich Small Caps Like CONMED Corporation Are Catching Analysts’ Eyes

CONMED Corporation, a player in the surgical device industry, is gaining attention in the small-cap stock arena, showcasing resilience amid economic turbulence. The company’s net income reached $33.8 million in Q4 2024, reflecting effective cost management and profitability, with annual revenue growth

7 March 2025

*EN·*TR·Action·AI Chips·Intel·News

Is Infosys at a Crossroads? AI’s Impact on Profitability Challenges the IT Giant

Infosys Limited, a leading consulting and technology firm, faces significant challenges due to the rise of artificial intelligence. AI offers potential operational efficiencies but threatens Infosys’s traditional business model reliant on IT outsourcing. Post-pandemic demand shifts have left Infosys with large projects

7 March 2025

Action·News·YouTube

Revolution in Cancer Treatment: Breakthrough Drug Offers New Hope for Leukemia Patients

Olverembatinib is a new third-generation BCR-ABL inhibitor approved in China, offering hope for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) patients. This groundbreaking drug is included in China’s National Reimbursement Drug List, highlighting its potential to transform

6 March 2025

1 2 3 … 613 Next

Action

MSC Income Fund Surprises Investors with Dividend Announcement

Why UnitedHealth Group’s Impressive ROE Is Not Translating Into Growth

Nasdaq’s Dramatic Decline: The Golden Opportunity for Savvy Investors

Xeris Biopharma’s Impressive Leap: Surpassing Expectations and Shaping the Future

Markets Unsettled: Tumultuous Week of Trade Policies and Rising Borrowing Costs

Surprise Developments at Domo: A Leap in Strategic Partnerships and Client Retention Drives Remarkable Growth

Costco Unveils Bold Expansion Plans and Strong Financials: What It Means for Shoppers

What the Future Holds for Small-Cap Stocks: A Deep Dive with LiveRamp Holdings

The Hidden Gems: Why Cash-Rich Small Caps Like CONMED Corporation Are Catching Analysts’ Eyes

Is Infosys at a Crossroads? AI’s Impact on Profitability Challenges the IT Giant

Revolution in Cancer Treatment: Breakthrough Drug Offers New Hope for Leukemia Patients

Latest Posts

MSC Income Fund Surprises Investors with Dividend Announcement

Why UnitedHealth Group’s Impressive ROE Is Not Translating Into Growth

The Untapped Wonders of Micro-Cap Stocks: Your Gateway to Extraordinary Gains

Nasdaq’s Dramatic Decline: The Golden Opportunity for Savvy Investors

Small-Cap Stocks Poised for a Big Comeback: Why Integral Ad Science Leads the Charge

Xeris Biopharma’s Impressive Leap: Surpassing Expectations and Shaping the Future